Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP916431.RA9KqH9QaB-TaYFIV94bvLnwq0ThLNMIf0CfBwWx74Q7Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP916431.RA9KqH9QaB-TaYFIV94bvLnwq0ThLNMIf0CfBwWx74Q7Y130_assertion type Assertion NP916431.RA9KqH9QaB-TaYFIV94bvLnwq0ThLNMIf0CfBwWx74Q7Y130_head.
- NP916431.RA9KqH9QaB-TaYFIV94bvLnwq0ThLNMIf0CfBwWx74Q7Y130_assertion description "[The development of small-molecule inhibitors against TMEM16A may be clinically relevant for treatment of human cancers, including SCCHN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916431.RA9KqH9QaB-TaYFIV94bvLnwq0ThLNMIf0CfBwWx74Q7Y130_provenance.
- NP916431.RA9KqH9QaB-TaYFIV94bvLnwq0ThLNMIf0CfBwWx74Q7Y130_assertion evidence source_evidence_literature NP916431.RA9KqH9QaB-TaYFIV94bvLnwq0ThLNMIf0CfBwWx74Q7Y130_provenance.
- NP916431.RA9KqH9QaB-TaYFIV94bvLnwq0ThLNMIf0CfBwWx74Q7Y130_assertion SIO_000772 22564524 NP916431.RA9KqH9QaB-TaYFIV94bvLnwq0ThLNMIf0CfBwWx74Q7Y130_provenance.
- NP916431.RA9KqH9QaB-TaYFIV94bvLnwq0ThLNMIf0CfBwWx74Q7Y130_assertion wasDerivedFrom befree-20150227 NP916431.RA9KqH9QaB-TaYFIV94bvLnwq0ThLNMIf0CfBwWx74Q7Y130_provenance.
- NP916431.RA9KqH9QaB-TaYFIV94bvLnwq0ThLNMIf0CfBwWx74Q7Y130_assertion wasGeneratedBy ECO_0000203 NP916431.RA9KqH9QaB-TaYFIV94bvLnwq0ThLNMIf0CfBwWx74Q7Y130_provenance.